NaturaGene-Ai: New Integrative Oncology Testing for Repurposed Drugs and Supplements
In the world of cancer care, one size rarely fits all. That’s why Datar Cancer Genetics—a leader in precision oncology—has introduced a groundbreaking testing solution designed for patients and practitioners who want to explore evidence-based integrative treatment options alongside conventional care.
The new NaturaGene-Ai Panel brings the same scientific rigor Datar uses to match patients with effective standard oncology treatments, but shifts the focus to repurposed drugs and supplements that research suggests may help fight cancer.
How NaturaGene-Ai Works
The NaturaGene-Ai report delivers a wealth of personalized data to help guide integrative treatment decisions, including:
- Genetic Analysis of 20,000+ Markers – Providing a deep look at your cancer’s unique genetic profile.
- Chemosensitivity Ranking – Measuring and ranking the tumor-cell-killing potential of 37 repurposed drugs and supplements.
- Pathway Mapping (KEGG) – Identifying over- or under-expressed cancer pathways.
- Supplement Impact List – Highlighting supplements that have been shown to positively influence irregular cancer pathways.
Treatments Examined in the Panel
The cancer cell death analysis evaluates a wide range of integrative compounds, such as:
- Ivermectin
- Mebendazole
- Multiple species of mistletoe
- Metformin
- Melatonin
- Fenbendazole
- Niclosamide
- EGCG (Epigallocatechin gallate)
- Chloroquine
- Ascorbic Acid (Vitamin C)
View Example NaturaGene-Ai Report
View List of Drugs & Supplements Tested In NaturaGene-Ai
Supplement Insights for Pathway Support
In addition to its chemosensitivity findings, NaturaGene-Ai may identify supplements that could help address improperly functioning cancer pathways. Examples include:
- Berberine
- Selenium
- Graviola
- Shiitake Extract
- Beta-Carotene
An Integrative Testing Option for Every Need
While NaturaGene-Ai provides the most comprehensive integrative guidance, Datar also offers Chemo-Scale—a targeted chemosensitivity test—for those who want results focused solely on cancer-cell-killing potential.
A complete list of the repurposed drugs and supplements tested through the chemosensitivity process along with an example report can be found here.
About Datar Cancer Genetics
Datar Cancer Genetics is a multinational, CMS- and CAP-licensed oncology laboratory specializing in blood-based cancer testing that spans the entire care continuum—from early diagnosis, to therapy guidance, to remission monitoring. Their mission is to deliver science-driven tools that help patients and providers make informed, individualized treatment decisions.
📩 To learn more or request testing, contact:
Dr. Keshia Tate
📧 DrKeshiaTate@BPCDX.com
📱 480-955-1094 (texts accepted)
